Pharmacy News

Nancy JW Lewis, Pharm.D., MPH

adjunct associate research scientist

University of Michigan College of Pharmacy

Consultant, Program Design and Research, Transcend the Binary

 

Stuart Rockafellow, Pharm.D.

consultant pharmacist

Northern Physicians Organization

 

Jack Earls

patient advocate and peer counselor

Transcend the Binary

 

Brayden A. Misiolek

executive director/oo-founder

Transcend the Binary

 The existence of health inequities within the U.S. are well documented.1-3 Such inequities are common among transgender/gender non-conforming (TGNC) individuals.2 who often have limited financial resources, face a scarcity of  competent, gender-affirming providers and have complex health needs.

 The TGNC Community

Defined as persons whose gender identities, gender expressions or behaviors do not conform to that typically associated with the sex they were assigned at birth,4 TGNC individuals compose about  0.6% of the U.S. population.5 They express their gender identities across a diverse spectrum that ranges from, and outside of, male and female. Selected gender identity terms are defined in Table 1.

TGNC individuals often encounter discrimination.6-10 In the 2015 National Transgender Survey (NTS),10 27,715 self-identified TGNC individuals reported discrimination in schools, workplaces, housing situations, and/or public places. High rates of physical and mental abuse, homelessness, low employment and economic hardship were also reported.10

The risk for discrimination extends into healthcare settings.9,11-14 The NTS reported that a third of respondents who saw a healthcare professional in the past year had at least one negative experience related to being transgender.9 A 2016 survey of 316 TGNC adults found that 41 percent of respondents indicated some degree of worry about discrimination with pharmacists.12  Thirteen percent of respondents reported that past experiences of purposeful embarrassment at a pharmacy caused them to avoid seeking healthcare most or some of the time. Experienced discrimination or worry about discrimination in healthcare settings is associated with anxiety, depression and overall poorer self-reported health.12, 15-17

Fear of discrimination within the traditional healthcare system leads some to seek alternative sources of care from other sources.18,19   The prevalence of hormone use with medications obtained outside of legitimate pharmacies is estimated to be as high as 70 percent among studied populations with rates varying based on geographical location and gender identity.14, 18,19

 Pharmacist and Pharmacy Technician Roles in Transgender Healthcare

Given that many (but not all) TGNC individuals seek hormone therapy to affirm their authentic gender (i.e., the gender to which they self-identify), pharmacy staff can play an important role in improving transgender healthcare.20-24  That role can be illustrated by the actions taken by one Michigan pharmacist, Darnell Jones.  In 2013, Darnell began practicing in the Palmer Park area of Detroit. He soon realized he was serving a community of TGNC patients that desperately needed access to medical care. Many patients obtained hormones from black market sources and few knew health providers that offered affordable, gender-affirming care. Darnell educated himself about transgender health, counseled patients about hormone therapy, established a referral process to transgender specialists and co-founded a TGNC advocacy organization, Transcend the Binary. Within a few years, his actions as a pharmacist and ally touched the lives of hundreds of TGNC individuals.

Darnell’s path to care began with researching the literature and discussions with TGNC patients and medical specialists. It is not uncommon for health professionals to have little or no formal education in transgender health. One study found that over 60 percent of pharmacy residents surveyed felt unprepared to provide care to TGNC patients.25 Fortunately, resources are available to assist pharmacy staff gain competency. The World Professional Association for Transgender Health (WPATH) Standards of Care26  is a foundational document for understanding transgender health. Organizations such as The Endocrine Society,27 University of California, San Francisco Transgender Health Clinic, 28 Lorde-Callen Clinic 29 and Fenway Clinic30 have published therapy guidelines. The National Center for Transgender Equality (https://transequality.org), Fenway Health (FenwayHealth.org) and Rainbow Health Ontario (https://www.rainbowhealthontario.ca) have online health professional educational resources. In Michigan, the Oakland County Pharmacists Association has partnered with TGNC advocates to offer a transgender health continuing education program. Numerous articles discuss appropriate pharmacological care for TGNC adult and/or adolescent patients. 31-38

The most meaningful learning, however, may be gained through interactions with TGNC individuals. Spending time at transgender medical practices, meeting with TGNC community members, and attending advocacy events can provide insight into the daily lives and health needs of this community. These interactions will likely highlight the numerous health-related risks existing within the TGNC community including depression, anxiety, suicidality, interpersonal trauma, substance abuse disorder, smoking and HIV/AIDS. 10, 17, 39-41

The foundation for transgender care is a non-threatening pharmacy environment.  Gender-affirming policies and practices respect the spectrum and fluidity of gender, protect patient confidentiality, engender trust in patient-pharmacy staff relationships and are responsive to patient needs. Table 2 lists actions that support a gender-affirming pharmacy practice and signal to TGNC patients that the pharmacy is a safe place to seek care. A gender-affirming pharmacy experience, however, begins when a patient walks through the building door. Therefore, all store staff should know how to provide gender-affirming service.

Potential services that pharmacy staff can implement to improve transgender care are described in Table 3. Pharmacists and pharmacy technicians wishing to establish gender-affirming practices should do so in consultation with individuals and organizations from the TGNC community so that services reflect an informed, intentional effort to respectful care.

 Conclusion

Transgender healthcare requires a skilled combination of evidence-based practice and culturally responsive care. It must understand and respond to the intersecting impacts of medical care, discrimination and social determinates that influence the health of this population. Pharmacists who undertake this challenging responsibility can improve the health of one of our most vulnerable populations.

 Table 1: Common Gender Terms

 Agender: genderless, internally identifies as neither male or female

Authentic gender: self-conception of gender identity

Bigender: gender identity is a combination of male and female

Cisgender: gender identity aligns with sex assigned at birth

Gender fluid: gender identity and presentation shift across gender spectrum

Genderqueer/gender nonbinary:  identity lies along or outside the gender spectrum

Transgender (or trans) female: identifies as female but assigned male at birth

Transgender (or trans) man: identifies as male but assigned female at birth

 (Adapted from references 4,36)

 

Table 2: Actions for Implementing a Gender-Affirming Pharmacy Practice

 Build bridges

 Post a notice that gender-inclusive care is provided, have LGBTQ-friendly pamphlets in the waiting area, or wear a lapel pin that has LGBTQ colors or indicates your chosen pronouns (e.g., she/her)

Establish a relationship with individual TGNC patients by letting them know that you wish to assist and support them in their therapy decisions

 Connect to the TGNC community by attending local TGNC events to gain first-hand knowledge of the needs and culture of this community

Visit the offices of local transgender specialists. Ask for opportunities to learn about their services and let them know that patients referred to you will receive respectful care

 Establish gender-affirming policies

 Collect and document preferred name and pronouns in the pharmacy profile for all patients and apologize immediately if the wrong name or the wrong pronoun is used

 Ensure that patients receive respectful care even if a specific staff member is uncomfortable dispensing hormone prescriptions for physical, mental and/or emotional alignment

 Create a consistent pharmacy policy about the dispensing of syringes and communicate that with all TGNC patients

 Establish a gender-neutral bathroom or a bathroom use policy that allows people to use the bathroom that is right for them

 Create a safe environment for patient care

 Use private areas for counseling 

 Ask, don’t challenge, patients about doses, dosage schedules or administration instructions that differ from general guidelines. These prescriptions offer opportunities for discussing patient therapy goals.

 Document verification of hormone prescriptions in the pharmacy profile so patients are not re-questioned about therapy appropriateness on future pharmacy visits.

 Avoid unnecessary personal questions that are not pertinent to patient care

 (References 42,43)

 

Table 3: Potential Services to Offer within a Gender-Affirming Pharmacy Practice

 Information and counseling about hormone therapy effects and side effects for patients who are considering whether such therapy is appropriate for them

 Information, education and therapy management for those prescribed hormone therapy

 Education about hormone injection techniques and assistance/coaching with initial hormone injections

 Assistance with obtaining hormone therapy at an affordable price, especially for those who have high co-payments or who lack prescription insurance

 Counseling about the use and safety of non-traditional health interventions commonly used by the TGNC community

 Referral information for gender-affirming medical providers and other health professionals or service and navigation organizations such as Trans Lifeline (1-877-565-8860), a national suicide and support hotline or Transcend the Binary (info@TranscendtheBinary.org), a Michigan-based advocacy and service navigation organization

 Offering of telephone or telecommunication counseling as an addition or substitute to in-pharmacy counseling

HIV screenings, counseling related to HIV pre-exposure prophylaxis (PrEP) and counseling and drug therapy management related to HIV treatment

 Tobacco cessation counseling

 Hepatitis C screenings, counseling and drug therapy management related to Hepatitis C treatment

 Hepatitis A immunizations

 Screenings, brief interventions and referrals to therapy for depression and substance abuse disorders

 (References 12, 20-24)

 

Contact:

Nancy JW Lewis, PharmD, MPH

njwlewis@umich.edu

248-805-4112

 

References

1.        Centers for Disease Control and Prevention. CDC Health Disparities and Inequalities Report — United States, 2011. MMWR 2011;60(Suppl):1-114.

2.        IOM (Institute of Medicine.) The health of lesbian, gay, bisexual, and transgender people: Building a foundation for better understanding. Washington, DC: The National Academies Press. 2011 (accessed 2017 April 14).

3.        National Academies of Sciences, Engineering, and Medicine. 2017. Communities in action: Pathways to health equity. Washington, DC: The National Academies Press.

4.        American Psychological Association. Definitions Related to Sexual Orientation and Gender Diversity in APA Documents. https://www.apa.org/pi/lgbt/resources/sexuality-definitions.pdf. (Accessed 2019 Feb. 1)

5.        Flores AR, Brown TNT, Herman JL. Race and ethnicity of adults who identify as transgender in the United States. The Williams Institute. 2016. (accessed 2017 Aug. 17).

6.        Bauer GR, Scheim AI, Deutsch MB, Massarella C. Reported emergency department avoidance, use, and experiences of transgender persons in Ontario, Canada: Results from a respondent-driven sampling survey. Ann Emerg Med. 2014;63:713-720.

7.        Bradford J, Reisner SL, Honnold JA, Xavier J. Experiences of transgender-related discrimination and implications for health: Results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103:1820-1829.

8.        Cruz TM. Assessing access to care for transgender and gender nonconforming people: A consideration of diversity in combating discrimination. Soc Sci Med. 2014;110:65-73.

9.        Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M.  Injustice at every turn: A report of the National Transgender Discrimination Survey. Washington: National Center for Transgender Equality and National Gay and Lesbian Task Force, 2011. (accessed 2017 Nov. 10).

10.     James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. 2016. (accessed 2015 Nov. 14).

11.     Lerner JE, Robels G. Perceived barriers and facilitators to health care utilization in the United States for transgender people: A review of recent literature. JHCPU. 2017;28:127-152.

12.     Lewis NJW, Batra P, Misiolek, B, et al. Transgender/gender non-conforming adults’ worry and coping actions related to discrimination: Relevance to pharmacist care. AJHP (in press.)

13.     Rodriguez, A , Agardh, Oppong Asamoah, B. Self-Reported Discrimination in Health-Care Settings Based on Recognizability as Transgender: A Cross-Sectional Study Among Transgender U.S. Citizens. Arch Sex Behav. (2018) 47:973–985.

14.     Sanchez NF. Sanchez JP, Danoff N. Healthcare utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009;99:713-719.

15.     Meyer HH, Brown TNT, Herman JL, et al. Demographic characteristics and health status of transgender adults in select US regions: Behavioral Risk Factor Surveillance System, 2014. Am J Public Health. 2017;107:582-289.

16.     Seelman KL, Colon-Diaz MJP, LeCroix RH, Xavier-Brier M, Kattari L. Transgender noninclusive healthcare and delaying care because of fear: Connections to general health and mental health among transgender adults. Transgender Health. 2017;1:17-28.

17.     Streed CG, McCarthy EP, Haas JS. Association between gender minority status and self-reported physical and mental health in the United States. JAMA Intern Med. 2017;77:1210-1212.

18.     Mepham N, Bouman WP, Arcelus J, et al. People with gender dysphoria who self-prescribe cross-sex hormones: Prevalence, sources, and side effects knowledge. J Sex Med. 2014;11:2995–3001.

19.     Rotondi NK, Bauer, GR, Scanlon K, Kaay M, Travers R, Travers A. Nonprescribed hormone use and self-performed surgeries: “Do-it-yourself” transitions in transgender communities in Ontario, Canada. Am J Public Health. 2013;103:1830–1836.

20.     Bonner L. Pharmacists can be accessible, trusted providers for transgender patients. Pharmacy Times. 2016. http://www.pharmacytoday.org/article/S1042-0991(16)00356-X/pdf. (accessed 2018 Feb. 10).

21.     Cocohoba J. Pharmacists caring for transgender persons. Am J Health-Syst Pharm. 2017;74:170-4.

22.     Maxwell E, Salch S, Boliko M, Anakwe-Charles G. Discrepancies in lesbian, gay, bisexual, and transgender patient care and how pharmacists can support an evolved practice. Am J Pharm Educ. 2017;1:1-4.

23.     Newsome C, Colip L, Sharon N. Conklin J. Incorporating a pharmacist into an interprofessional team providing transgender care under a medical home model. Am J Health-Syst Pharm. 2017; 74:135-9.

24.     Radix AE. Pharmacists’ role in provision of transgender healthcare. Am J Health-Syst Pharm. 2017;74:103-104.

25.     Leach C, Layson-Wolf C. Survey of community pharmacy residents’ perceptions of transgender health management. JAPhA. 2016:56:441-445.

26.     Coleman E, Bockting W, Bother M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. Int J Transgend. 2011;13:165–232.

27.     Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal H et al. Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94: 3132–3154, 2009

28.     Deutsch MB ed. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. Center of Excellence for Transgender Health. University of California, San Francisco. 2016.

29.     Callen-Lorde Community Health Center. Protocols for the provision of hormone therapy. Available at http://callen-lorde.org/transhealth/( accessed 2017 March 11).

30.     Makadon HJ, Mayer, KH, Piotter P, Goldhammer H. Fenway guide to lesbian, gay, bisexual, and transgender health, 2nd ed. Boston: The Fenway Institute; 2015.

31.     Bass M, Gonzalez LJ, Colip L, Sharon N, Conklin J. Rethinking gender: The nonbinary approach. AJHP. 2018;75:1821-1823.

32.     Bishop BM. Pharmacotherapy considerations in the management of transgender patients: A brief review. Pharmacotherapy. 2015;35: 1130-1139.

33.     Chew D, Anderson J, Williams K, et al. Hormonal treatment in young people With gender dysphoria: A systematic review. Pediatrics. 2018;141(4):e20173742

34.     Daniel H and Butkus R. Lesbian, gay, bisexual, and transgender health disparities: Executive summary of a policy position paper from the American College of Physicians. Ann Intern Med. 2015;163:135-137.

35.     Gabe Murchison, G. Supporting & caring for transgender children. American College of Osteopathic Pediatricians, American Academy of Pediatrics and the Human Rights Campaign Foundation, 2016. (accessed 2019 Feb. 5)

36.     Klein DA, Paradise SL, Goodwin ET. Caring for transgender and gender-diverse persons: What clinicians should know. Am Fam Physician. 2018;98:645-653.

37.     Levine DA, and the Committee on Adolescence. Office-based care for lesbian, gay, bisexual, transgender, and questioning youth. Pediatrics. 2013:e297-e313. Technical Report.

38.     Shumer De, Nokoff NJ, Spck NP. Advances in the care of transgender children and adolescents. Advances in Pediatrics. 63 (2016) 79–102.

39.     Nuttbrock L, Bockting W, Rosenblum A, et al. Gender Abuse, Depressive Symptoms, and Substance Use Among Transgender Women: A 3-Year Prospective Study. Am J Public Health. 2014;104:2199–2206.

40.     Trujillo MA, Perrin PB, Sutter M, Tabaac A, Benotsch. The buffering role of social support on the associations among discrimination, mental health, and suicidality in a transgender sample. Int J Transgenderism. 2017;18:39–52.

41.     Valentine SE, Shipherd JC. A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States. Clinical Psychology Review. 2018;66:24–38.

42.     Human Rights Campaign Foundation. Providing LGBTQ-inclusive care and services at your pharmacy: a resource guide for pharmacists and pharmacy staff. June 2016. https://www.hrc.org/resources/providing-lgbtq-inclusive-care-and-services-at-your-pharmacy. (accessed 2017 Sept. 15).

43.     Community Conversation: Finding our Strength. (Community Forum Discussion). Transcend the Binary, Ferndale MI. Aug. 30, 2018.

 


Comments

There are currently no comments, be the first to post one.

Post Comment

Only registered users may post comments.